SANDOZ WAKES: CIBA MERGER GIVES COMPANY FOCUS THROUGH END OF DECADE; NOVARTIS WILL BE 8TH LARGEST U.S. FIRM, LOOKING FOR $1.5 BIL. IN SAVINGS WORLDWIDE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".